Using the data mining of gene expression profiles and the clinical sample-based validations, we first showed that CXCL13 was highly expressed in young breast cancer, and closely associated with some prognostic factors including lymph node positive and ER negative in young breast cancer. The gene discussed is CXCL13; the disease is breast carcinoma.